SCHEMBL4766263

SCHEMBL4766263

COc1ccc(Nc2ncnc3[nH]c(-c4cccc(CN5CCN(C)CC5)c4)cc23)cc1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 6/20 0.46
RET P07949 2/20 0.46
KIF5B P33176 1/20 0.46
EGFR P00533 9/20 0.44
TLR8 Q9NR97 2/20 0.44
TLR7 Q9NYK1 2/20 0.44
BRAF P15056 2/20 0.44
RAF1 P04049 1/20 0.44
ERBB2 P04626 4/20 0.43
PDGFRB P09619 3/20 0.43
AURKB Q96GD4 3/20 0.43
AURKA O14965 2/20 0.43
TEK Q02763 2/20 0.43
FLT4 P35916 1/20 0.43
TLR9 Q9NR96 1/20 0.43
STK10 O94804 1/20 0.42
MAP4K4 O95819 1/20 0.42
ABL1 P00519 1/20 0.42
YES1 P07947 1/20 0.42
BCR P11274 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4767297 0.92 KDR (0.49) KDRRETKIF5BEGFRBRAF
SCHEMBL4771139 0.90 BRAF (0.45) KDRRETEGFRBRAFERBB2
SCHEMBL4768562 0.85 RET (0.49) KDRRETKIF5BEGFRBRAF
SCHEMBL4766666 0.83 CSF1R (0.59) KDRRETKIF5BEGFRBRAF
SCHEMBL5565132 0.82 RET (0.55) KDRRETKIF5BEGFRBRAF
SCHEMBL4767157 0.82 AXL (0.52) KDRRETEGFRERBB2PDGFRB
SCHEMBL8259330 0.81 RET (0.58) KDRRETKIF5BEGFRBRAF
SCHEMBL4768916 0.81 KDR (0.51) KDRRETEGFRBRAFERBB2
SCHEMBL4766845 0.78 RET (0.54) KDRRETKIF5BEGFRBRAF
SCHEMBL4766930 0.77 KDR (0.54) KDRRETEGFRBRAFERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1416935-B1 4-AMINO-6-PHENYL-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES NOVARTIS AG (CH) 2008-03-12 EP claimed
US-7244729-B2 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives NOVARTIS AG (CH) 2007-07-17 US claimed
US-20040248911-A1 7H-pyrrolo[2,3-d]pyrimidine derivatives BOLD GUIDO (CH) 2004-12-09 US claimed
EP-1416935-B1 4-AMINO-6-PHENYL-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES NOVARTIS AG (CH) 2008-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040248911-A1 7H-pyrrolo[2,3-d]pyrimidine derivatives DPYD, DHPS, TYMP KDR 3031/4885RET 2696/4885KIF5B 3135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.